News | AP VALVES & SH 2023

14-Year’s Journey of AMC TAVR

“TAVR has become the standard of care for patients with symptomatic severe aortic stenosis, regardless of age or specific cases.”

News | AP VALVES & SH 2023

RENOVATE Trial

NOAC in Mechanical AVR: Is There a Hope?

News | AP VALVES & SH 2022

SAVR always better for younger AS? 'Durability data up to 10-years greenlights TAVR for patients between 65-70'

Long-term valve durability becomes crucial for younger AS populations; intermediate-term data strengthens case for TAVR in select patients under 70 years

News | AP VALVES & SH 2022

Data on TAVR-related stroke 'not enough, hard to justify routine EPD use except in BAV, ViVs,'

David J. Cohen, MD says field 'just not that good' at predicting TAVR-related stroke and its effects, but EPDs help patients with bicuspid valves, ViV procedures for now

News | AP VALVES & SH 2022

Not just alternative to SAVR: 'TAVR has become standard of treatment for severe, symptomatic AS'

AMC Heart Institute's Chairman Seung-jung Park, MD, PhD says 'For Tissue Valves, SAVR is Alternative to TAVR' in Severe, Symptomatic AS Patients Over 65 Years

News | AP VALVES & SH 2022

Promising new TAVR techniques, valves to realize ideal of '1 procedure, 1 valve' for life

Eberhard Grube, MD Addresses THV Newcomers, Caveats in Evolving Field of TAVR at AP VALVES & SH 2022

News | AP VALVES & SH 2022

Celebrating 2 decades of TAVI: How 1 inventor, pioneer pushed heart history forward

Renowned French physician, interventional cardiologist Alain G. Cribier recognizes advancements, achievements of 20-year TAVI journey at AP VALVES & SH 2022